MEDICAL OUTCOMES MANAGEMENT, INC.
Advancing Population Healthcare
OUR PROJECTS
Since Medical Outcomes Management began in 1991, we’ve provided our services to a variety of organizations.
On every project we undertake, our most important objective is to relate to our clients and understand their core necessities and goals.
Below are some examples of the work we’ve done - take a look, and get in touch to learn more.
PATIENT-CENTERED OUTCOMES RESEARCH INSTITUTE (PCORI®)
BESTMED: Observational Evaluation of Second line Therapy Medications in Diabetes.
Medical Outcomes Management is pleased to announce that it is a major participant in the Patient Centered Outcomes Research Institute (PCORI) funded study BESTMED: Observational Evaluation of Second line Therapy Medications in Diabetes. Dr. Alan Kaul, the President and founder of Medical Outcomes Management and the Practice Research Network (PRACnet) is honored to be a Dual Principal Investigator in the study.
The BESTMED study will use a large database of electronic patient data to compare medications used to treat Type 2 diabetes mellitus including a) DPP4 inhibitors; b) GLP1 receptor agonists; c) basal insulin; d) SGLT2 inhibitors and e) sulfonylureas to determine which ones offer the best balance of risks and benefits. This database will be drawn from a patient population of over 130 million.
​
The BESTMED study started in July 2021. Study findings are expected in 2024-2025.
​
For additional information see:
https://www.BESTMED.org
PATIENT-CENTERED OUTCOMES RESEARCH INSTITUTE (PCORI®)
Practice Research Network-PRACnet
Partnered with a large, national healthcare insurer to write white papers, fulfill contractual requirements, propose and plan future projects, broaden extant and develop new relationships related to PCORI contracts.
THE NATIONAL PATIENT-CENTERED CLINICAL RESEARCH NETWORK (PCORNET®)
PCORnet®
Developed strategic alliances with PCORnet Clinical Research Networks (CRNs) representing a diverse set of patients and institutions. By combining a robust infrastructure and research expertise, we used a common data model covering millions of patients to help answer medical questions important to patients, their caregivers, and the overall medical community.
PEOPLE-CENTERED RESEARCH FOUNDATION (PCRF®)
PCRF
As a member of the project management team, we defined strategic clinical and financial objectives. Founded PRACnet as a contributing CRN.
GET WITH THE GUIDELINES
American Heart Association
Coronary Artery Disease (CAD)
Engagement with AHAÂ in the development and outreach of the flagship initiative for the secondary prevention of coronary artery disease.
COST EFFECTIVENESS CONCEPTS
Major Biotechnology Company
Developed educational speaker slide decks and webinar content detailing tools of CE concepts as related to biotechnology products such as those used to treat rheumatoid arthritis.
PROVIDER EDUCATION OUTREACH
Horizon Blue Cross-Blue Shield, Hill Physicians Medical Group, Harvard Pilgrim Healthcare, Aetna Health
Developed clinical practice guidelines consistent with evidence based medicine that incorporated drug utilization review and education outreach. Improved practices in treating diseases (I.e., osteoporosis, hypertension, and migraine).
PERIPHERAL ARTERIAL OCCLUSION
ABBOTT
Conducted a sentinel cost-effectiveness study comparing outcomes, length-of-stay, and hospital charges among therapeutic alternatives (thrombolytic drugs and surgery) for treating peripheral arterial occlusion.
IMPROVING THE TREATMENT OF DYSLIPIDEMIAS
Merck
Developed and conducted a summit meeting the world’s experts addressing the treatment of cardiovascular disease and dyslipidemias. Published the findings as a special supplement to the American Journal of Cardiology.
TREATINGÂ PERIPHERAL VASCULAR DISEASE
Abbott Laboratories
Developed, published, and provided continuing education accreditation for physicians and pharmacists with a monograph about treating peripheral vascular disease. Published and handled fulfillment to 25,000 physicians and pharmacists.
RESPONDING TO AN EVOLVING HEALTHCARE ENVIRONMENT
Rhone-Poulenc Rorer (now a division of Sanofi)
Partnered with management to identify and understand changes in public and private health care policy, interpreted the likely business implications, and formulated appropriate responses.
PATIENT-CENTERED OUTCOMES RESEARCH INSTITUTE (PCORI®)
Practice Research Network-PRACnet
Partnered with a large, national healthcare insurer to write white papers, fulfill contractual requirements, propose and plan future projects, broaden extant and develop new relationships related to PCORI contracts.
THE NATIONAL PATIENT-CENTERED CLINICAL RESEARCH NETWORK (PCORNET®)
PCORnet®
Developed strategic alliances with PCORnet Clinical Research Networks (CRNs) representing a diverse set of patients and institutions. By combining a robust infrastructure and research expertise, we used a common data model covering millions of patients to help answer medical questions important to patients, their caregivers, and the overall medical community.
PEOPLE-CENTERED RESEARCH FOUNDATION (PCRF®)
PCRF
As a member of the project management team, we defined strategic clinical and financial objectives. Founded PRACnet as a contributing CRN.
GET WITH THE GUIDELINES
American Heart Association
Coronary Artery Disease (CAD)
Engagement with AHAÂ in the development and outreach of the flagship initiative for the secondary prevention of coronary artery disease.
COST EFFECTIVENESS CONCEPTS
Major Biotechnology Company
Developed educational speaker slide decks and webinar content detailing tools of CE concepts as related to biotechnology products such as those used to treat rheumatoid arthritis.
PROVIDER EDUCATION OUTREACH
Horizon Blue Cross-Blue Shield, Hill Physicians Medical Group, Harvard Pilgrim Healthcare, Aetna Health
Developed clinical practice guidelines consistent with evidence based medicine that incorporated drug utilization review and education outreach. Improved practices in treating diseases (I.e., osteoporosis, hypertension, and migraine).
PERIPHERAL ARTERIAL OCCLUSION
ABBOTT
Conducted a sentinel cost-effectiveness study comparing outcomes, length-of-stay, and hospital charges among therapeutic alternatives (thrombolytic drugs and surgery) for treating peripheral arterial occlusion.
IMPROVING THE TREATMENT OF DYSLIPIDEMIAS
Merck
Developed and conducted a summit meeting the world’s experts addressing the treatment of cardiovascular disease and dyslipidemias. Published the findings as a special supplement to the American Journal of Cardiology.
TREATINGÂ PERIPHERAL VASCULAR DISEASE
Abbott Laboratories
Developed, published, and provided continuing education accreditation for physicians and pharmacists with a monograph about treating peripheral vascular disease. Published and handled fulfillment to 25,000 physicians and pharmacists.
RESPONDING TO AN EVOLVING HEALTHCARE ENVIRONMENT
Rhone-Poulenc Rorer (now a division of Sanofi)
Partnered with management to identify and understand changes in public and private health care policy, interpreted the likely business implications, and formulated appropriate responses.
PATIENT-CENTERED OUTCOMES RESEARCH INSTITUTE (PCORI®)
Practice Research Network-PRACnet
Partnered with a large, national healthcare insurer to write white papers, fulfill contractual requirements, propose and plan future projects, broaden extant and develop new relationships related to PCORI contracts.
THE NATIONAL PATIENT-CENTERED CLINICAL RESEARCH NETWORK (PCORNET®)
PCORnet®
Developed strategic alliances with PCORnet Clinical Research Networks (CRNs) representing a diverse set of patients and institutions. By combining a robust infrastructure and research expertise, we used a common data model covering millions of patients to help answer medical questions important to patients, their caregivers, and the overall medical community.
PEOPLE-CENTERED RESEARCH FOUNDATION (PCRF®)
PCRF
As a member of the project management team, we defined strategic clinical and financial objectives. Founded PRACnet as a contributing CRN.
GET WITH THE GUIDELINES
American Heart Association
Coronary Artery Disease (CAD)
Engagement with AHAÂ in the development and outreach of the flagship initiative for the secondary prevention of coronary artery disease.
COST EFFECTIVENESS CONCEPTS
Major Biotechnology Company
Developed educational speaker slide decks and webinar content detailing tools of CE concepts as related to biotechnology products such as those used to treat rheumatoid arthritis.
PROVIDER EDUCATION OUTREACH
Horizon Blue Cross-Blue Shield, Hill Physicians Medical Group, Harvard Pilgrim Healthcare, Aetna Health
Developed clinical practice guidelines consistent with evidence based medicine that incorporated drug utilization review and education outreach. Improved practices in treating diseases (I.e., osteoporosis, hypertension, and migraine).
PERIPHERAL ARTERIAL OCCLUSION
ABBOTT
Conducted a sentinel cost-effectiveness study comparing outcomes, length-of-stay, and hospital charges among therapeutic alternatives (thrombolytic drugs and surgery) for treating peripheral arterial occlusion.
IMPROVING THE TREATMENT OF DYSLIPIDEMIAS
Merck
Developed and conducted a summit meeting the world’s experts addressing the treatment of cardiovascular disease and dyslipidemias. Published the findings as a special supplement to the American Journal of Cardiology.
TREATINGÂ PERIPHERAL VASCULAR DISEASE
Abbott Laboratories
Developed, published, and provided continuing education accreditation for physicians and pharmacists with a monograph about treating peripheral vascular disease. Published and handled fulfillment to 25,000 physicians and pharmacists.
RESPONDING TO AN EVOLVING HEALTHCARE ENVIRONMENT
Rhone-Poulenc Rorer (now a division of Sanofi)
Partnered with management to identify and understand changes in public and private health care policy, interpreted the likely business implications, and formulated appropriate responses.
PATIENT-CENTERED OUTCOMES RESEARCH INSTITUTE (PCORI®)
Practice Research Network-PRACnet
Partnered with a large, national healthcare insurer to write white papers, fulfill contractual requirements, propose and plan future projects, broaden extant and develop new relationships related to PCORI contracts.
THE NATIONAL PATIENT-CENTERED CLINICAL RESEARCH NETWORK (PCORNET®)
PCORnet®
Developed strategic alliances with PCORnet Clinical Research Networks (CRNs) representing a diverse set of patients and institutions. By combining a robust infrastructure and research expertise, we used a common data model covering millions of patients to help answer medical questions important to patients, their caregivers, and the overall medical community.
PEOPLE-CENTERED RESEARCH FOUNDATION (PCRF®)
PCRF
As a member of the project management team, we defined strategic clinical and financial objectives. Founded PRACnet as a contributing CRN.
GET WITH THE GUIDELINES
American Heart Association
Coronary Artery Disease (CAD)
Engagement with AHAÂ in the development and outreach of the flagship initiative for the secondary prevention of coronary artery disease.
COST EFFECTIVENESS CONCEPTS
Major Biotechnology Company
Developed educational speaker slide decks and webinar content detailing tools of CE concepts as related to biotechnology products such as those used to treat rheumatoid arthritis.
PROVIDER EDUCATION OUTREACH
Horizon Blue Cross-Blue Shield, Hill Physicians Medical Group, Harvard Pilgrim Healthcare, Aetna Health
Developed clinical practice guidelines consistent with evidence based medicine that incorporated drug utilization review and education outreach. Improved practices in treating diseases (I.e., osteoporosis, hypertension, and migraine).
PERIPHERAL ARTERIAL OCCLUSION
ABBOTT
Conducted a sentinel cost-effectiveness study comparing outcomes, length-of-stay, and hospital charges among therapeutic alternatives (thrombolytic drugs and surgery) for treating peripheral arterial occlusion.
IMPROVING THE TREATMENT OF DYSLIPIDEMIAS
Merck
Developed and conducted a summit meeting the world’s experts addressing the treatment of cardiovascular disease and dyslipidemias. Published the findings as a special supplement to the American Journal of Cardiology.
TREATINGÂ PERIPHERAL VASCULAR DISEASE
Abbott Laboratories
Developed, published, and provided continuing education accreditation for physicians and pharmacists with a monograph about treating peripheral vascular disease. Published and handled fulfillment to 25,000 physicians and pharmacists.
RESPONDING TO AN EVOLVING HEALTHCARE ENVIRONMENT
Rhone-Poulenc Rorer (now a division of Sanofi)
Partnered with management to identify and understand changes in public and private health care policy, interpreted the likely business implications, and formulated appropriate responses.
PATIENT-CENTERED OUTCOMES RESEARCH INSTITUTE (PCORI®)
Practice Research Network-PRACnet
Partnered with a large, national healthcare insurer to write white papers, fulfill contractual requirements, propose and plan future projects, broaden extant and develop new relationships related to PCORI contracts.
THE NATIONAL PATIENT-CENTERED CLINICAL RESEARCH NETWORK (PCORNET®)
PCORnet®
Developed strategic alliances with PCORnet Clinical Research Networks (CRNs) representing a diverse set of patients and institutions. By combining a robust infrastructure and research expertise, we used a common data model covering millions of patients to help answer medical questions important to patients, their caregivers, and the overall medical community.
PEOPLE-CENTERED RESEARCH FOUNDATION (PCRF®)
PCRF
As a member of the project management team, we defined strategic clinical and financial objectives. Founded PRACnet as a contributing CRN.
GET WITH THE GUIDELINES
American Heart Association
Coronary Artery Disease (CAD)
Engagement with AHAÂ in the development and outreach of the flagship initiative for the secondary prevention of coronary artery disease.
COST EFFECTIVENESS CONCEPTS
Major Biotechnology Company
Developed educational speaker slide decks and webinar content detailing tools of CE concepts as related to biotechnology products such as those used to treat rheumatoid arthritis.
PROVIDER EDUCATION OUTREACH
Horizon Blue Cross-Blue Shield, Hill Physicians Medical Group, Harvard Pilgrim Healthcare, Aetna Health
Developed clinical practice guidelines consistent with evidence based medicine that incorporated drug utilization review and education outreach. Improved practices in treating diseases (I.e., osteoporosis, hypertension, and migraine).
PERIPHERAL ARTERIAL OCCLUSION
ABBOTT
Conducted a sentinel cost-effectiveness study comparing outcomes, length-of-stay, and hospital charges among therapeutic alternatives (thrombolytic drugs and surgery) for treating peripheral arterial occlusion.
IMPROVING THE TREATMENT OF DYSLIPIDEMIAS
Merck
Developed and conducted a summit meeting the world’s experts addressing the treatment of cardiovascular disease and dyslipidemias. Published the findings as a special supplement to the American Journal of Cardiology.
TREATINGÂ PERIPHERAL VASCULAR DISEASE
Abbott Laboratories
Developed, published, and provided continuing education accreditation for physicians and pharmacists with a monograph about treating peripheral vascular disease. Published and handled fulfillment to 25,000 physicians and pharmacists.
RESPONDING TO AN EVOLVING HEALTHCARE ENVIRONMENT
Rhone-Poulenc Rorer (now a division of Sanofi)
Partnered with management to identify and understand changes in public and private health care policy, interpreted the likely business implications, and formulated appropriate responses.